The lack of differences in both the CD4+ and CD8+ responses between the breakthrough and non-breakthrough group are likely influenced by a combination of factors including the severity of the breakthrough infection, the immunogenicity of the SARS-CoV-2 variants, and the duration between the virus infection [51]. This evidence concerns the gene CD8A and viral infectious disease.